We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+26.3%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.15B
AUM Growth
+$601M
Cap. Flow
+$483M
Cap. Flow %
42.15%
Top 10 Hldgs %
60.26%
Holding
693
New
300
Increased
46
Reduced
89
Closed
249

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$403M
2
HES
Hess
HES
+$46.3M
3
SLV icon
iShares Silver Trust
SLV
+$26M
4
AMZN icon
Amazon
AMZN
+$20.5M
5
EMB icon
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
+$16M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$82.8M
2
JPM icon
JPMorgan Chase
JPM
+$54.1M
3
BABA icon
Alibaba
BABA
+$51.1M
4
DE icon
Deere & Co
DE
+$31.8M
5
JD icon
JD.com
JD
+$14.3M

Sector Composition

Rank Sector Weight
1 Technology 14%
2 Energy 7.45%
3 Consumer Discretionary 7.05%
4 Utilities 4.19%
5 Healthcare 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EAF icon
101
GrafTech
EAF
$212M
$634K 0.06%
+7,942
New +$596K
OKTA icon
102
Okta
OKTA
$25.8B
$633K 0.06%
3,163
-12,741
-80% -$2.16M
PETS icon
103
PetMed Express
PETS
$42.3M
$633K 0.06%
+17,763
New +$617K
INOV
104
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$631K 0.06%
32,746
+20,420
+166% +$362K
IPAR icon
105
Interparfums
IPAR
$3.94B
$630K 0.06%
13,078
+8,707
+199% +$392K
FIVN icon
106
FIVE9
FIVN
$2.54B
$628K 0.05%
+5,672
New +$552K
DRNA
107
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$628K 0.05%
24,733
+12,311
+99% +$265K
MEDP icon
108
Medpace
MEDP
$16.5B
$616K 0.05%
+6,618
New +$563K
TARO
109
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$590K 0.05%
8,871
– –
NAVI icon
110
Navient
NAVI
$853M
$587K 0.05%
+83,497
New +$621K
FN icon
111
Fabrinet
FN
$20.1B
$585K 0.05%
+9,376
New +$575K
NTAP icon
112
NetApp
NTAP
$37.2B
$580K 0.05%
13,075
+6,510
+99% +$280K
RTX icon
113
RTX Corp
RTX
$301B
$578K 0.05%
+9,373
New +$585K
OKE icon
114
Oneok
OKE
$54.5B
$575K 0.05%
17,301
-32,953
-66% -$1.07M
QLYS icon
115
Qualys
QLYS
$6.35B
$557K 0.05%
5,355
-2,333
-30% -$244K
INVA icon
116
Innoviva
INVA
$1.48B
$553K 0.05%
39,534
-2,410
-6% -$32.8K
WHF icon
117
WhiteHorse Finance
WHF
$146M
$550K 0.05%
53,380
-23,383
-30% -$217K
SMTC icon
118
Semtech
SMTC
$13B
$544K 0.05%
+10,426
New +$488K
AFG icon
119
American Financial Group
AFG
$12.1B
$543K 0.05%
+8,549
New +$551K
LDOS icon
120
Leidos
LDOS
$17.3B
$543K 0.05%
+5,793
New +$571K
MKTX icon
121
MarketAxess Holdings
MKTX
$5.72B
$541K 0.05%
+1,080
New +$503K
ABBV icon
122
AbbVie
ABBV
$435B
$540K 0.05%
+5,500
New +$484K
SPGI icon
123
S&P Global
SPGI
$120B
$539K 0.05%
1,637
+576
+54% +$173K
CME icon
124
CME Group
CME
$94.8B
$537K 0.05%
3,301
-4,076
-55% -$731K
TRTN
125
DELISTED
Triton International Limited
TRTN
$537K 0.05%
17,751
-13,893
-44% -$413K
3 4
5
6 7

Similar funds

BFM
Boston Financial Management Boston, Massachusetts $3.31B AUM 19.4% 1-Year Est. Return
MWM
Merriman Wealth Management Seattle, Washington $2.4B AUM 13.66% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
ECG
Edge Capital Group Atlanta, Georgia $2.24B AUM 19.7% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
KL
KGH Ltd Nassau, Bahamas $1.92B AUM 13.96% 1-Year Est. Return
WP
WMS Partners Towson, Maryland $1.78B AUM 11.82% 1-Year Est. Return
RDIA
RE Dickinson Investment Advisors Council Bluffs, Iowa $1.77B AUM 15.45% 1-Year Est. Return

Caxton Associates (New York)'s Q2 2020 Portfolio in Review

As of Q2 2020, Caxton Associates (New York) held 693 positions worth $1.15B, up 111% from $544M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Caxton Associates (New York) deployed $483M of net new capital in Q2 2020, opening 300 new positions and adding to 46 existing holdings. Its largest new stake was Hess: 1,011,414 shares worth $52.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 27% a quarter earlier, followed by Energy and Consumer Discretionary.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $54.1M trimmed.

  • Caxton Associates (New York)'s largest Q2 2020 buy was Hess: 1,011,414 shares worth $52.4M.
  • Caxton Associates (New York) added most to SPDR Gold Trust in Q2 2020, an estimated $403M increase.
  • Caxton Associates (New York)'s biggest Q2 2020 reduction was JPMorgan Chase, cutting an estimated $54.1M.
  • Caxton Associates (New York) fully exited Microsoft in Q2 2020, selling an estimated $82.8M.
  • Caxton Associates (New York)'s ten largest holdings make up 60% of its $1.15B portfolio in Q2 2020.
  • Caxton Associates (New York) opened 300 new positions and closed 249 in Q2 2020.
  • Caxton Associates (New York)'s portfolio value rose 111% quarter-over-quarter to $1.15B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2020, filed 14 Aug 2020.